CCDC124 Antibody

Western Blot: CCDC124 Antibody [NBP2-48858] -

Western Blot: CCDC124 Antibody [NBP2-48858] - The expression of IL‐25 affects the cisplatin resistance of lung cancer cells. A, The expression of IL‐25 in A549 & A549/CDDP cells. B, IL‐25 overexpressed in A549 cells. C, silence of IL‐25 expression by siRNA in A549/CDDP cells. D, IL‐25 overexpression desensitizes A549 cells to cisplatin treatment. E, Silence of IL‐25 expression sensitizes A549/CDDP cells to cisplatin treatment. *P < 0.01 vs indicated controls, all figures represent the average of three sets of independent experiments Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/31044552), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: CCDC124 Antibody [NBP2-48858] -

Western Blot: CCDC124 Antibody [NBP2-48858] - IL‐25 regulates the NF‐ kappaB signaling pathway activity. A, The change of NF‐ kappaB signaling pathway in IL‐25 overexpressed A549 cells & IL‐25 silenced A549/CDDP cells. B, The effect of exogenous IL‐25 on the activity of NF‐ kappaB signaling pathway in A549 cells. C, QNZ blocks the effect of exogenous IL‐25 on the expression of major vault protein (MVP) & the activity of NF‐ kappaB signaling pathway in A549 cells. *P < 0.01 vs indicated controls, all figures represent the average of three sets of independent experiments Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/31044552), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: CCDC124 Antibody [NBP2-48858] -

Western Blot: CCDC124 Antibody [NBP2-48858] - The expression of IL‐25 affects the cisplatin resistance of lung cancer cells. A, The expression of IL‐25 in A549 & A549/CDDP cells. B, IL‐25 overexpressed in A549 cells. C, silence of IL‐25 expression by siRNA in A549/CDDP cells. D, IL‐25 overexpression desensitizes A549 cells to cisplatin treatment. E, Silence of IL‐25 expression sensitizes A549/CDDP cells to cisplatin treatment. *P < 0.01 vs indicated controls, all figures represent the average of three sets of independent experiments Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/31044552), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: CCDC124 Antibody [NBP2-48858] -

Western Blot: CCDC124 Antibody [NBP2-48858] - The expression of IL‐25 affects the cisplatin resistance of lung cancer cells. A, The expression of IL‐25 in A549 & A549/CDDP cells. B, IL‐25 overexpressed in A549 cells. C, silence of IL‐25 expression by siRNA in A549/CDDP cells. D, IL‐25 overexpression desensitizes A549 cells to cisplatin treatment. E, Silence of IL‐25 expression sensitizes A549/CDDP cells to cisplatin treatment. *P < 0.01 vs indicated controls, all figures represent the average of three sets of independent experiments Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/31044552), licensed under a CC-BY license. Not internally tested by Novus Biologicals.